Peter Lynch fit · Growth at a reasonable price (GARP)
Is ANI Pharmaceuticals, Inc. (ANIP) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
64/100
CSinais mistos
4/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a ANIP
PEG ≤ 1.0
chave-
EPS CAGR ≥ 15%
chave-
Revenue CAGR ≥ 10%
42.2%
Net margin > 0
8.6%
Como ANIP pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$1.88B
P/L (TTM)
18.5x
ROIC (TTM)
8.17%
Margem bruta
65.94%
Outras análises Peter Lynch
Perguntas frequentes
What is ANIP's Peter Lynch fit score?
ANIP scores 64/100 on our Peter Lynch fit engine - grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own ANIP?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ANIP.
How often is this score updated?
ANIP's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende ANIP pessoalmente.